Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/enSLlL2TPt #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical
Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/en
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
@Raider93162286 @axelkahn J'ai attiré l'attention de M. Kahn sur l'étude OnCovid qui indique presque 3 fois moins de morts chez les patients cancéreux prenant de l'hydroxychloroquine. Mais il n'a pas daigné commenter. Les patients atteints du cancer sont-i
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of #COVID_19 treatments and #clinical outcomes among patients with #cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study https://t.co/U7vmbf92XT
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
A paper about EMERSE for cancer research appears in this issue. https://t.co/VWsyYDuVDr
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @COVID19nCCC: Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patie…
RT @COVID19nCCC: Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patie…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patie…
RT @COVID19nCCC: Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort st…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of #COVID19 Tx & clinical outcomes among patients w/ cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7lINKLnZi #AACRCovid #COVID19nCancer Fig2 Heatmap of selected clinical
Hydroxychloroquine + any other drug assoc w/ incr mortality --> Utilization of #COVID19 Tx & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @gary_lyman: #CCC19 #oncoalert Racial Disproportionality in Covid Clinical Trials | NEJM https://t.co/uB0MNkzWUd @NicoleKuderer @COVID19…
RT @gary_lyman: #CCC19 #oncoalert Racial Disproportionality in Covid Clinical Trials | NEJM https://t.co/uB0MNkzWUd @NicoleKuderer @COVID19…
RT @gary_lyman: #CCC19 #oncoalert Racial Disproportionality in Covid Clinical Trials | NEJM https://t.co/uB0MNkzWUd @NicoleKuderer @COVID19…
RT @gary_lyman: #CCC19 #oncoalert Racial Disproportionality in Covid Clinical Trials | NEJM https://t.co/uB0MNkzWUd @NicoleKuderer @COVID19…
RT @gary_lyman: #CCC19 #oncoalert Racial Disproportionality in Covid Clinical Trials | NEJM https://t.co/uB0MNkzWUd @NicoleKuderer @COVID19…
#CCC19 #oncoalert Racial Disproportionality in Covid Clinical Trials | NEJM https://t.co/uB0MNkzWUd @NicoleKuderer @COVID19nCCC @CD_AACR Covid-19 trials need to target populations at greatest risk esp Black, Latinx, & Native American. Our studies concu
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study [Jul 22, 2020] Rivera et al. @CD_AACR https://t.co/v7lINKLnZi #CCC19 #AACRCovid #COVID19 #COVID19nCancer @COVID19nCCC
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
RT @meansell: Cancer Discovery Article about use of Remdesivir: https://t.co/NT2z9oINZB #MLANet20
Cancer Discovery Article about use of Remdesivir: https://t.co/NT2z9oINZB #MLANet20
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @UNMC_DrKhan: Cancer registry data: #Hydroxychloroquine combined with any other treatment appeared significantly associated with increas…
Cancer registry data: #Hydroxychloroquine combined with any other treatment appeared significantly associated with increased risk for 30-day all-cause mortality. Conversely, HCQ alone did not appear to increase mortality risk; obviously didn't decrease. ht
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/v7lINKLnZi #AACRCov
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC…
RT @NatRevClinOncol: A COVID-19 and Cancer Consortium (CCC19) cohort study provides insights into the utilization of COVID-19 treatments an…
A COVID-19 and Cancer Consortium (CCC19) cohort study provides insights into the utilization of COVID-19 treatments and clinical outcomes among patients with cancer: https://t.co/t4dQsIOaxX #COVID19
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study @CD_AACR @TMWiseDraper @UCHealthNews @SWOG https://t.co/OxoTZeHZR1
Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19) cohort study [Jul 22, 2020] Rivera @peters_solange et al. @gary_lyman @hemoncwarner @CD_AACR https://t.co/enSLlL2TPt #AACRCov
RT @COVID19nCCC: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC…
RT @KarinPurshouse: Further analysis from @COVID19nCCC looking @ outcomes of >2000 patients with #cancer and #COVID19 - worth noting in the…
RT @SylvesterCancer: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium…
RT @SylvesterCancer: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium…
RT @SylvesterCancer: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
Further analysis from @COVID19nCCC looking @ outcomes of >2000 patients with #cancer and #COVID19 - worth noting in the UK patients with cancer are eligible for #recoverytrial - important to do RCT where there is genuine equipoise around gold standard c
RT @SylvesterCancer: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @SylvesterCancer: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium…
RT @SylvesterCancer: Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium…
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study - @GlopesMd among coauthors. https://t.co/4SfG97v0uv
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @COVID19nCCC: Utilization of #COVID19 treatments & clinical outcomes among patients with cancer: A COVID-19 & Cancer Consortium (#CCC19)…
RT @montypal: Great data by @PGrivasMDPhD @DrChoueiri on the utilization of COVID-19 TXs & clinical outcomes among pts w/ cancer. Findings…